Stocktoria
YD Bio Ltd YDES
Nasdaq · XNAS · stock · Services-Medical Laboratories · website · IPO 2025-08-29
YD Bio Ltd statistics & valuation
Market cap$188.4M
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 |
|---|---|---|
| Gross margin | 28.1% | 30.4% |
| Operating margin | -883.3% | -286.5% |
| Net margin | -1392.6% | -276.6% |
| FCF margin | -1346.6% | -254.3% |
| Return on assets | -60.3% | -20.6% |
| Return on equity | 291.0% | -21.4% |
| Current ratio | 5.88 | 13.18 |
| Revenue growth | 16.9% | — |
Source: SEC EDGAR filings · CIK 0002011674 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.